CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH 
The Centers for Disease Control and Prevention (CDC) has released its “US Selected Practice Recommendations for Contraceptive Use, 2024” (2024 US SPR), offering updated guidance for healthcare providers on contraceptive methods. This evidence-based document, published in the Morbidity and Mortality Weekly Report, aims to enhance the quality and equity of contraceptive care while prioritizing patient autonomy in decision-making.
Key Points:
- The 2024 US SPR provides new recommendations on medications for IUD placement, management of bleeding irregularities during implant use, and self-administration of injectable contraception.
- Misoprostol is not recommended for routine IUD placement but may be useful in specific circumstances. Lidocaine may help reduce patient pain during the procedure.
- For bleeding irregularities during implant use, the guidance outlines treatment options with varying durations of effectiveness.
- The document addresses testosterone use and pregnancy risk in transgender, gender-diverse, and nonbinary individuals, emphasizing the need for contraceptive counseling.
- Self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is recommended as an additional approach for injectable contraception, with studies showing higher continuation rates compared to provider-administered methods.
- The guidance stresses the importance of a person-centered approach in contraceptive decision-making, respecting individual preferences and reproductive autonomy.
- The CDC used systematic reviews, expert input, and patient perspectives to develop these recommendations, employing the Grading of Recommendations Assessment, Development and Evaluation approach to assess evidence certainty.
“A person-centered approach prioritizes individual preferences and reproductive autonomy, respects the person as the main decision-maker, and includes respecting the decision not to use contraception or to discontinue use.”
More on Contraception/Pregnancy
